Total Payments
$76,871
2024 Payments
$4,550
Companies
9
Transactions
63
Payment Breakdown by Category
Other$34,415 (44.8%)
Consulting$30,328 (39.5%)
Research$5,037 (6.6%)
Travel$4,570 (5.9%)
Food & Beverage$2,521 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $30,328 | 11 | 39.5% |
| Grant | $30,000 | 2 | 39.0% |
| Unspecified | $5,037 | 9 | 6.6% |
| Travel and Lodging | $4,570 | 13 | 5.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,415 | 3 | 5.7% |
| Food and Beverage | $2,521 | 25 | 3.3% |
Payments by Type
General
$71,833
54 transactions
Research
$5,037
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $30,174 | 4 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $14,306 | 12 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $12,467 | 21 | $0 (2024) |
| National Marrow Donor Program | $6,741 | 10 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $5,250 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,654 | 8 | $0 (2018) |
| Medexus Pharma, Inc. | $2,040 | 1 | $0 (2024) |
| Genentech USA, Inc. | $1,166 | 4 | $0 (2022) |
| GENZYME CORPORATION | $73.82 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,550 | 8 | Medexus Pharma, Inc. ($2,040) |
| 2023 | $29,430 | 16 | Incyte Corporation ($12,565) |
| 2022 | $22,270 | 10 | Incyte Corporation ($17,500) |
| 2021 | $6,721 | 4 | JAZZ PHARMACEUTICALS INC. ($5,120) |
| 2020 | $49.36 | 1 | Novartis Pharmaceuticals Corporation ($49.36) |
| 2019 | $4,481 | 7 | Novartis Pharmaceuticals Corporation ($4,481) |
| 2018 | $4,654 | 8 | E.R. Squibb & Sons, L.L.C. ($4,654) |
| 2017 | $4,716 | 9 | Novartis Pharmaceuticals Corporation ($4,716) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $771.93 | General |
| 08/07/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.56 | General |
| 07/31/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | — | Cash or cash equivalent | $445.62 | Research |
| Study: Research Publication/ Writing Support • Category: Oncology | ||||||
| 07/01/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 06/06/2024 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $129.60 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/28/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.51 | General |
| 02/22/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $108.69 | General |
| Category: Hematology/Oncology | ||||||
| 01/08/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: Oncology | ||||||
| 10/16/2023 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $238.18 | General |
| 09/27/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $9,875.00 | General |
| 09/27/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $197.94 | General |
| 09/27/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $36.06 | General |
| 08/31/2023 | Incyte Corporation | — | Grant | Cash or cash equivalent | $12,500.00 | General |
| 07/13/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $336.55 | General |
| 07/13/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $64.47 | General |
| 07/13/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $44.09 | General |
| 07/13/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $26.72 | General |
| 07/13/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $26.72 | General |
| 07/12/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $855.64 | General |
| 07/05/2023 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $189.04 | General |
| 05/12/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 04/28/2023 | National Marrow Donor Program | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| 03/24/2023 | National Marrow Donor Program | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 02/16/2023 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $65.00 | General |
| 12/14/2022 | Incyte Corporation | — | Grant | Cash or cash equivalent | $17,500.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $4,592 | 8 |
| Research Publication/ Writing Support | Novartis Pharmaceuticals Corporation | $445.62 | 1 |
About Dr. Muna Qayed, MD
Dr. Muna Qayed, MD is a Pediatric Hematology-Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508074568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muna Qayed, MD has received a total of $76,871 in payments from pharmaceutical and medical device companies, with $4,550 received in 2024. These payments were reported across 63 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($30,328).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Atlanta, GA
- Active Since 05/21/2007
- Last Updated 06/06/2022
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1508074568
Products in Payments
- KYMRIAH (Biological) $6,346
- DEFITELIO (Drug) $5,250
- ORENCIA (Biological) $4,654
- KYMRIAH (Drug) $1,071
- JAKAFI (Drug) $108.69
- MOZOBIL (Drug) $73.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Atlanta
Robert Sidonio, Md, MD
Pediatric Hematology-Oncology — Payments: $898,589
Pediatric Hematology-Oncology $898,589
Shannon Meeks, Md, MD
Pediatric Hematology-Oncology — Payments: $366,833
Pediatric Hematology-Oncology $366,833
Bhavya Doshi, M.d, M.D
Pediatric Hematology-Oncology — Payments: $177,468
Pediatric Hematology-Oncology $177,468
Vivien Sheehan, Md, MD
Pediatric Hematology-Oncology — Payments: $100,331
Pediatric Hematology-Oncology $100,331
Carlton Dampier, Md, MD
Pediatric Hematology-Oncology — Payments: $72,327
Pediatric Hematology-Oncology $72,327
Shanmuganathan Chandrakasan, Md, MD
Pediatric Hematology-Oncology — Payments: $43,728
Pediatric Hematology-Oncology $43,728